340: Crisis in CRISPR world, RFK Jr.'s promises, and a novel non-opioid pain drug
The Readout Loud
Intro
The hosts introduce key themes around the CRISPR gene editing industry, addressing its challenges and future prospects. They highlight recent earnings reports, significant political votes, and breakthroughs in biotechnology, setting the stage for an in-depth discussion.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
